Publication | Closed Access

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

VaccinationCross-protectionVaccine DevelopmentMedicineTlr5 Ligand FlagellinImmunologyVirologyInfluenza M2eInfluenza VaccineVaccine DesignFlu VaccinationPotent ImmunogenicityInfluenza Vaccines